Hepatic circulatory diseases associated with chronic myeloid disorders.
These liver diseases are diseases of the hepatic circulation. Myeloproliferative disorders are among the most common prothrombotic disorders that lead to Budd-Chiari syndrome and PVT. SOS, previously known as hepatic veno-occlusive disease, is mainly seen in North America and Western Europe as a complication of the conditioning regimen for hematopoietic stem cell transplantation. SOS is caused by damage to SECs, and the initiating circulatory blockage occurs because of the embolism of sinusoidal lining cells. Myeloproliferative disorders are an uncommon cause of NRH, which is believed to be caused by uneven perfusion of the liver at the venous or sinusoidal level. Peliosis hepatis is believed to result from damage to SECs and is seen mainly in immunosuppressed patients, patients with a wasting illness, or patients with a drug toxicity.
Poreddy
Vijayrama
V
Division of Gastrointestinal and Liver Diseases, University of Southern California Keck School of Medicine, 2011 Zonal Avenue, HMR 603, Los Angeles, CA 90293, USA.
DeLeve
Laurie D
LD
D006502:Budd-Chiari Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006504:Hepatic Veno-Occlusive Disease / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications*; D008099:Liver / Q000473:pathology; D008102:Liver Circulation; D009190:Myelodysplastic Syndromes / Q000150:complications*; D009196:Myeloproliferative Disorders / Q000150:complications*; D010382:Peliosis Hepatis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D011169:Portal Vein; D012307:Risk Factors; D020246:Venous Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy